This report provides all the information you require to better understand Bayer and its partnering interests and activities over the past seven years.
Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets that it is looking for further takeover pharma deals.
Private equity firms are circling Bayer’s €10bn plastics business merger, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said yesterday.
Bayer is a top pharmaceutical company based in Leverkusen, Germany
Bayer is offering to swap its animal health assets for Merck & Co Inc’s consumer healthcare business, people familiar with the matter said on Tuesday, in a move that could give the German drugmaker a leg up in the $14 billion auction of the Merck business.
Sorry, your search returned no results.
X-Chem has licensed a second drug discovery program to Bayer Pharma pursuant to the multi-target collaboration the companies established in July 2012
Bayer HealthCare and Kyoto University’s Office of Society-Academia Collaboration for Innovation pharma partners by signing a two-year agreement to jointly identify candidates for possible collaborative research projects.
MetaSysX announce the closure of a pharma deal with Bayer CropScience for the coming three years to apply its metabolomics technologies for improving agricultural productivity.
Big pharma Bayer will spin off its plastics unit as the company moves further toward focusing solely on the life sciences market.
Quantum Materials acquires five diverse sets of patent families from Bayer Technology Services.
Big pharma, Bayer announced a $100,000 donation to the American Red Cross to support the organization’s national disaster and emergency preparedness efforts across the United States.
Big Pharma, Bayer presented New York City Police Commissioner William J. Bratton with a $50,000 donation to the Police Athletic League of New York City in support of its STEM (science, technology, engineering and mathematics) educational programs.
Boston Scientific has entered into a definitive agreement to acquire the Interventional Division of Bayer for $415 million in cash, including fees for transitional services.
Bayer and Merck & Co also agreed to enter into a strategic pharma deal collaboration in the area of cardiovascular diseases with a focus on sGC modulation.